For example, it is reported that myeloid-specific IKKβ deficiency can improve obese-dependent systemic insulin resistance (77, 87), indicating that myeloid cell IKKβ plays a role in systemic insulin resistance and inflammation in obesity. Here, IKBKB is linked to obesity due to melanocortin 4 receptor deficiency.